Nel ASA’s October Report Looms as the Defining Test in a Vacuum of News

The Norwegian electrolyser manufacturer has entered a peculiar stretch of its corporate life: no fresh company announcements, no analyst upgrades or downgrades, no regulatory filings to chew on. For investors accustomed to a steady drip of catalysts, the current silence is itself becoming the story. The last substantive word from Oslo came with the half-year numbers in mid-July, and since then the share has been left to drift on its own momentum.

That momentum has been decidedly sideways. The stock closed Friday at EUR 0.1960, up 1.8 percent on the day, yet the 30-day picture tells a less flattering tale: a 0.9 percent decline that suggests the latest uptick has barely scratched the surface of a mild downtrend. More starkly, the shares sit roughly 46 percent below their 52-week high of EUR 0.3655 — a gap that underscores just how far the equity has fallen from the levels it commanded in the spring.

What makes the current lull particularly uncomfortable is the leadership vacuum at the top. Chief executive Håkon Volldal announced his departure in June with a six-month notice period, and no successor has been named. Until the board resolves that question, the strategic uncertainty hanging over the company is unlikely to lift, regardless of what the financial statements show.

A Second Quarter That Still Defines the Narrative

The fundamentals that investors must work with are hardly encouraging. Nel reported second-quarter 2026 revenue from customer contracts of NOK 153 million, a 12 percent slide year-on-year. EBITDA landed at minus NOK 155 million — deeply in the red and a reminder that the path to profitability remains distant. With no updated business figures since, these numbers continue to anchor the bearish case.

The share’s technical position offers little comfort either. The stock is trading just beneath its 50-day moving average of EUR 0.1996, hovering in a consolidation band that has held for weeks. Below that, the 200-day average sits at EUR 0.2132, a level the shares currently trail by 8.1 percent. The relative strength index at 47.9 points to neither oversold nor overbought conditions, suggesting the market has yet to make up its mind.

While the market waits for clarity, prudent leadership means preparing for every scenario — including the operational risks that can surface when attention is elsewhere. A free toolkit with 41 ready-to-use checklists helps you document workplace hazards properly and stay compliant. Download the free Risk Assessment Toolkit

Should investors sell immediately? Or is it worth buying Nel ASA?

The Commercial Rollout Hasn’t Moved the Needle

One development that might have been expected to shift sentiment was the start of commercial marketing of the company’s electrolyser technology roughly a month ago. Instead, the shares have shed around 28.7 percent since that milestone — a decline that speaks to the market’s impatience with announcements that lack hard monetisation data. The commercial launch, in other words, has been priced in and then some; what investors now want is evidence that the pipeline is converting into actual orders.

That makes the third-quarter report, scheduled for October 21, the single most consequential event on the calendar. It will provide the first concrete data on whether the commercial rollout is translating into revenue or merely into press releases. A fourth-quarter update follows on February 18, 2027, but for now all eyes are on the October numbers.

Two Scenarios, One Pivot Point

The bull case rests on the possibility that Nel can demonstrate accelerating order intake and tangible progress on project execution. Given the stock’s 30-day volatility of 22 percent, a positive surprise could generate outsized moves. A confirmed ramp-up in commercial activity, backed by visible revenue effects, would puncture the narrative that the company has missed its window and could open the door to a recovery toward the 100-day average of EUR 0.2332.

The bear case is equally straightforward. If the October report again delivers progress reports without hard figures — or worse, reveals further project delays — the market may conclude that the monetisation phase is taking longer than hoped. That would cement the shares’ position below the 200-day average and raise the risk of a retest of the 52-week low of EUR 0.1731. Negative headlines in the run-up to the report, whether about delayed projects or weak order intake, could accelerate that drift.

A Stock Waiting for Its Catalyst

For now, Nel’s shares remain in a holding pattern, caught between a news vacuum and the anticipation of October 21. The absence of fresh information has left the stock trading on expectations rather than fundamentals, a situation that cannot persist indefinitely. The third-quarter report will either validate the patience of those who have held on through the summer or confirm the skepticism that has built over recent weeks.

The CEO question adds another layer of complexity. Until a successor to Volldal is announced, the company’s strategic direction remains an open question — one that no quarterly earnings release can fully resolve. Between the leadership uncertainty and the need to prove that commercial momentum can translate into orders, Nel faces a defining autumn. The October report is the first chance to answer both concerns with something more substantial than words.